Response to Comment on Lee et al. Sodium –Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study. Diabetes Care 2021; 44:2419–2426

We would like to thank Feldman-Billard and Paques (1) for their interest in our article (2) and for expressing their concern that our findings could raise an overabundance of caution about the risk of retinal vein occlusion (RVO) associated with the new use of sodium –glucose cotransporter 2 (SGLT2) inhibitors in elderly patients with chronic kidney disease (CKD).
Source: Diabetes Care - Category: Endocrinology Source Type: research